Angiotensinogen metabolism in rat aorta: Robust formation of proangiotensin-12

Journal of Physiology and Pharmacology

Volumn 61, Issue 6, 2010, Pages 679-682

  Bujak Gizycka, B ^a   Olszanecki, R ^a   Suski, M ^a   Madej, J ^a   Stachowicz, A ^a   Korbut, R ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Angiotensin; Angiotensin converting enzyme (ACE); Proangiotensin 12; Renin

Indexed keywords

ANGIOTENSIN I; ANGIOTENSINOGEN; PROANGIOTENSIN 12; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; EX VIVO STUDY; GENOMIC FRAGMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE METABOLISM; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; ANGIOTENSINS; ANIMALS; AORTA; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 79251527249     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. New angiotensins. J Mol Med 2008; 86(6): 663-671.
2. Kramkowski K, Mogielnicki A, Leszczynska A, Buczko W. Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats. J Physiol Pharmacol 2010; 61(3): 317-324.
3. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun 2006; 350(4): 1026-1031.
4. Jessup JA, Trask AJ, Chappell MC, et al. Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol 2008; 294(6): H2614-H2618.
5. Trask AJ, Jessup JA, Chappell MC, Ferrario CM. Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart. Am J Physiol Heart Circ Physiol 2008; 294(5): H2242-H2247.
6. Prosser HC, Forster ME, Richards AM, Pemberton CJ. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics. Cardiovasc Res 2009; 82(1): 40-50.
7. Prosser HC, Richards AM, Forster ME, Pemberton CJ. Regional vascular response to proAngiotensin-12 (PA12) through the rat arterial system. Peptides 2010; 31(8): 1540-1545.
8. Cummins PM. A new addition to the renin-angiotensin peptide family: proAngiotensin-12 (PA12). Cardiovasc Res 2009; 82(1): 7-8.
9. Cheng ZJ, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit 2005; 11(6): RA194-RA205.
10. Sata M, Fukuda D. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest 2010; 57(1-2): 12-25.
11. Li H, Yuan G. Electrospray ionization mass spectral characteristics and fragmentation mechanisms of Angiotensin II and its analogues. Int J Mass Spectrom 2006; 252(1): 54-60.
12. Bujak-Gizycka B, Madej J, Wolkow PP, et al. Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography - electrospray ionization - mass spectrometry (LC-ESI-MS). J Physiol Pharmacol 2007; 58(3): 529-540.
13. Olszanecki R, Madej J, Suski M, Gebska A, Bujak-Gizycka B, Korbut R. Angiotensin metabolism in rat stomach wall: prevalence of angiotensin-(1-7) formation. J Physiol Pharmacol 2009; 60(1): 191-196.
14. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78(1): 31-39.
15. Hering L, Herse F, Geusens N, et al. Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension 2010; 56(2): 311-318.
16. Klett C, Muller F, Gierschik P, Hackenthal E. Angiotensin II stimulates angiotensinogen synthesis in hepatocytes by a pertussis toxin-sensitive mechanism. FEBS Lett 1990; 259(2): 301-304.
17. Klett C, Hellmann W, Ganten D, Hackenthal E. Tissue distribution of angiotensinogen mRNA during experimental inflammation. Inflammation 1993; 17(2): 183-197.
18. Klett CP, Printz MP, Bader M, Ganten D, Eggena P. Angiotensinogen messenger RNA stabilization by angiotensin II. J Hypertens Suppl 1996; 14(5): S25-S36.
19. Kobori H, Ohashi N, Katsurada A, et al. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens 2008; 2(5): 349-354.
20. Soden M, Klett C, Hasmann T, Hackenthal E. Angiotensinogen: an acute-phase protein? Hypertension 1994; 23(Suppl 1): I126-I130.
21. Toton-Zuranska J, Gajda M, Pyka-Fosciak G, et al. AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice. J Physiol Pharmacol 2010; 61(2): 181-183.
22. Oparil S, Yarows SA, Patel S, Zhang J, Satlin A. Dual inhibition of the renin system by aliskiren and valsartan. Lancet 2007; 370(9593): 1126-1127.